Jump to full article: Independent Newspapers Ltd. / STUFF (nz), 2002-07-09
Author: TAMARA McLEAN
Intro: Manukau residents will be the first to breathe easier when ground-breaking research into treatment for smoking-related diseases is trialled locally next year.
South Auckland Health has a $3.6 million grant to set up a research centre with Fisher and Paykel Healthcare, targeting breakthrough treatments for chronic bronchitis and emphysema.
Chronic obstructive pulmonary disease (COPD), also known as "smoker's lung", is predicted to be the fifth major cause of death worldwide by 2020. . .
Manukau's high rates of "smoker's lung" make it the most logical location for research, says Middlemore Hospital's academic head of medicine, Dr Harry Rea, who leads a team of 10 researchers.
The researchers, funded for four years by the Foundation for Research, Science and Technology, will work to improve the design of nebulisers and humidifiers used to relieve COPD symptoms.
Jump to full article » |